Alemtuzumab-induced thyroid dysfunction - follow up data from the Northern Irish cohort

被引：0
|
作者：
Kennedy, Fiona [1 ]
Kiernan, Sinead [1 ]
Magill, Fiona [1 ]
Ormston, Tom [2 ]
Ike, Kelechi [2 ]
Kee, Rachael [1 ]
Johnston, Philip [1 ]
Gray, Orla [3 ]
Campbell, Jamie [4 ]
Droogan, Aidan [1 ]
Hughes, Stella [1 ]
McDonnell, Gavin [1 ]
机构：
[1] Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland
[2] Queens Univ Belfast, Belfast, Antrim, North Ireland
[3] South Eastern Hlth & Social Care Trust, Dundonald, North Ireland
[4] Southern Hlth & Social Care Trust, Portadown, North Ireland
来源：
NEUROLOGY | 2020年 / 94卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
3995
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Alemtuzumab-induced thyroid dysfunction - follow up data from the Northern Irish cohort
    Kennedy, F.
    Kiernan, S.
    Magill, F.
    Ormston, T.
    Ike, K.
    Kee, R.
    Johnston, P.
    Gray, O.
    Campbell, J.
    Droogan, A.
    Hughes, S.
    McDonnell, G.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 554 - 555
  • [2] Alemtuzumab-induced thyroid dysfunction examined
    [J]. Reactions Weekly, 2018, 1708 (1) : 2 - 2
  • [3] Alemtuzumab-Induced Autoimmune Thyroid Dysfunction
    Ragavan, Sharanniyan
    Elhelw, Omar
    Majeed, Waseem
    Kyriacou, Angelos
    Syed, Akheel
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (03)
  • [4] Alemtuzumab-induced thyroid disease: observational data from an Italian cohort of patients
    Moiola, L.
    Nozzolillo, A.
    Frau, J.
    Cocco, E.
    Manzoni, M.
    Di Filippo, L.
    Lanzillo, R.
    Bresciamorra, V.
    Valerio, C.
    Pia, A.
    Capobianco, M.
    Malucchi, S.
    Bertolotto, A.
    Rinaldi, F.
    Margoni, M.
    Zaffaroni, M.
    Lapucci, C.
    Inglese, M.
    Mirabella, M.
    Bianco, M. A.
    Patti, F.
    Chisari, C.
    Cavalla, P.
    Vercellino, M.
    Zanetta, C.
    Comi, G.
    Filippi, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 879 - 880
  • [5] Alemtuzumab-induced thyroid disease: observational data from an Italian cohort of patients
    Moiola, L.
    Nozzolillo, A.
    Di Filippo, L.
    Zanetta, C.
    Manzoni, M.
    Lapucci, C.
    Laroni, A.
    Mirabella, M.
    Bianco, A.
    Morra, V. Brescia
    Lanzillo, R.
    Russo, C. V.
    Margoni, M.
    Rinaldi, F.
    Zaffaroni, M.
    Patti, F.
    Chisari, C. G.
    Cavalla, P.
    Vercellino, M.
    Cocco, E.
    Frau, J.
    Capobianco, M.
    Bertolotto, A.
    Malucchi, S.
    Pia, A. R.
    Comi, G.
    Filippi, M.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 349 - 349
  • [6] Alemtuzumab-induced thyroid disease: A Danish cohort study
    Hansen, Juliana Frohnert
    Magyari, Melinda
    Rasmussen, ase Krogh
    Sellebjerg, Finn
    Feldt-Rasmussen, Ulla
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 91
  • [7] Alemtuzumab-Induced Thyroid Dysfunction Exhibits Distinctive Clinical and Immunological Features
    Pariani, Nadia
    Willis, Mark
    Muller, Ilaria
    Healy, Sarah
    Nasser, Taha
    McGowan, Anne
    Lyons, Greta
    Jones, Joanne
    Chatterjee, Krishna
    Dayan, Colin
    Robertson, Neil
    Coles, Alasdair
    Moran, Carla
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (08): : 3010 - 3018
  • [8] Letter to the Editor: "Alemtuzumab-Induced Thyroid Dysfunction Exhibits Distinctive Clinical and Immunological Features"
    Garrahy, Aoife
    Murphy, Nuala P.
    Byrne, Maria M.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (09): : 3624 - 3625
  • [9] Response to Letter to the Editor: "Alemtuzumab-Induced Thyroid Dysfunction Exhibits Distinctive Clinical and Immunological Features"
    Thakar, Ravi
    Gajewska-Knapik, Katarzyna
    Ogilvy-Stuart, Amanda L.
    Chatterjee, Krishna
    Moran, Carla
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (09): : 3626 - 3627
  • [10] Thyroid Storm in a Patient With Alemtuzumab-Induced Graves' Disease: A Case Report
    AlShehri, Sara
    Alajmi, Sarah
    Ekhzaimy, Aishah
    Aldawas, Sadeem
    Alalwan, Maryam
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
12345